Salido, Eduardo

Glycolate oxidase is a safe and efficient target for substrate reduction therapy in a mouse model of primary hyperoxaluria type I

Martin-Higueras, C., Luis-Lima, S., & Salido, E. (2016) · Molecular Therapy

Kidney Stones and Urolithiasis TreatmentsMetabolism and Genetic Disorders

Cited by 83

Inhibition of glycolate oxidase with dicer-substrate siRNA reduces calcium oxalate deposition in a mouse model of primary hyperoxaluria type 1

Dutta, C., Avitahl-Curtis, N., Pursell, N., Larsson Cohen, M., Holmes, B., Diwanji, R., Zhou, W., Apponi, L., Koser, M., Ying, B., et al. (2016) · Molecular Therapy

Kidney Stones and Urolithiasis TreatmentsRNA Interference and Gene Delivery

Cited by 81

DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.

Hernández-Pérez, S., Cabrera, E., Salido, E., Lim, M., Reid, L., Lakhani, S. R., Khanna, K. K., Saunus, J. M., & Freire, R. (2017) · Oncogene

Ubiquitin and proteasome pathwaysMicrotubule and mitosis dynamics

Cited by 61

Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome

Medina-Arana, V., Delgado, L., González, L., Bravo, A., Díaz, H., Salido, E., Riverol, D., González-Aguilera, J. J., & Fernández-Peralta, A. M. (2011) · Familial Cancer

Genetic factors in colorectal cancerAdrenal and Paraganglionic Tumors

Cited by 36

Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis

Gil-Farina, I., Di Scala, M., Salido, E., López-Franco, E., Rodríguez-García, E., Blasi, M., Merino, J., Aldabe, R., Prieto, J., & Gonzalez-Aseguinolaza, G. (2016) · The Journal of Immunology

Liver Diseases and ImmunityDrug-Induced Hepatotoxicity and Protection

Cited by 30